A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2023
This article has no abstract
Epistemonikos ID: 5139eecb7436107e62daa7aa9cc6cd4d55491910
First added on: Apr 11, 2025